Document Type
Article
Publication Date
9-17-2025
Abstract
BACKGROUND: Factors influencing in-hospital mortality in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) remain understudied, highlighting gaps in optimizing acute clinical outcomes. This study aimed to identify sociodemographic and clinical predictors of all-cause in-hospital mortality in this population.
METHODS: Using 2016 - 2020 data from the National Inpatient Sample (NIS), patients with malignant well-differentiated GEP-NETs were identified via the International Classification of Diseases, 10th Revision (ICD-10) codes. The primary outcome was in-hospital mortality. Sociodemographic and clinical variables (heart failure (HF), malnutrition, Charlson Comorbidity Index (CCI), and tumor site) were analyzed using multivariable logistic regression.
RESULTS: Among 5,642 patients (mean age 64, standard deviation (SD) 12.9), multivariable analysis identified HF (adjusted odds ratio (aOR) 2.09, 95% confidence interval (CI): 1.10 - 3.95), malnutrition (aOR 1.84, 95% CI: 1.29 - 2.62), pancreatic (aOR 1.52, 95% CI: 1.01 - 2.30) or colon tumors (aOR 2.31, 95% CI: 1.51 - 3.53), CCI ≥ 5 (aOR 1.49, 95% CI: 1.06 - 2.10), hypertension (aOR 0.65, 95% CI: 0.47 - 0.91) and elective admissions (aOR 0.40, 95% CI: 0.25 - 0.63) as clinically relevant factors associated with in-hospital mortality.
CONCLUSIONS: Advanced age, tumor location, malnutrition, and HF may be critical mortality predictors among patients with GEP-NETs. These findings advocate for integrated care models prioritizing nutritional support, cardiovascular monitoring, and early elective interventions to improve outcomes.
Recommended Citation
Obomanu, Elvis; Verinumbe, Tarfa; Anebo, Tinsae; Jones, Colton; and Dourado, Claudia, "Predictors of All-Cause In-Hospital Mortality in Patients With Malignant Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors" (2025). Einstein Health Papers. Paper 55.
https://jdc.jefferson.edu/einsteinfp/55
Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
Language
English
Included in
Internal Medicine Commons, Investigative Techniques Commons, Neoplasms Commons, Oncology Commons


Comments
This article is the author’s final published version in World Journal of Oncology, Volume 16, Issue 5, 2025, Pages 478-486.
The published version is available at https://doi.org/10.14740/wjon2614. Copyright © 2025 The authors.